Tumor markers in clinical practice: General principles and guidelines.
about
The use of sensitive chemical antibodies for diagnosis: detection of low levels of EpCAM in breast cancerNovel tools for prostate cancer prognosis, diagnosis, and follow-upIdentification of Gene-Expression Signatures and Protein Markers for Breast Cancer Grading and Staging.Detection of the potential pancreatic cancer marker MUC4 in serum using surface-enhanced Raman scatteringRole of serum carcinoembryonic antigen in the detection of colorectal cancer before and after surgical resection.Cancers Screening in an Asymptomatic Population by Using Multiple Tumour MarkersAssessment of Cytokeratin-19 Gene Expression in Peripheral Blood of Breast Cancer Patients and Breast Cancer Cell Lines.Tumor markers: A diagnostic toolEvaluation of 12-lipoxygenase (12-LOX) and plasminogen activator inhibitor 1 (PAI-1) as prognostic markers in prostate cancer.A need for cautious interpretation of elevated serum germ cell tumor markers in children. Review and own experiences.The need for effective pancreatic cancer detection and management: a biomarker-based strategy.Lactate dehydrogenase as a biomarker in oral cancer and oral submucous fibrosis.Diagnostic challenges of bHCG interpretation following gonadectomy in a patient with Swyer syndrome.Concordance analysis of paired cancer antigen (CA) 15-3 and 27.29 testing.The prognostic value of histidine-rich glycoprotein RNA in breast tissue using unmodified gold nanoparticles assay.The Role of the Vagus Nerve in Cancer Prognosis: A Systematic and a Comprehensive ReviewLow molecular weight proteins and enzymes in the urine of patients with bladder cancer - a pilot study
P2860
Q28486906-9901D265-BD8F-4977-838A-9099E96A89DBQ33625338-BA7A4EDF-FF82-49AF-8D13-DC6576E9A53AQ35777081-B03C6043-9257-43A8-A769-EC0E340885D9Q35860052-E125AE6F-FAF2-4E5A-A78B-B31BB3A2FC42Q35929207-A4F6C204-694E-432B-97ED-F782B001E6C0Q36063865-CBB1FC89-1F6A-451B-B76E-12F28153609FQ36856910-1313A1E4-A135-446B-8BC7-2837737CE292Q37591660-D53F3767-EFD7-4557-9E05-CE2EEBFE4DC0Q37695659-31E6387D-EB33-42F2-838F-45D6FDAD897AQ38578540-704BA795-A674-4187-BC8C-230E24F55245Q38591066-032DC105-B0FC-4E79-B075-D3720D9A23E9Q38873429-5353399E-F0C2-4BD5-A593-99A0671FF9CDQ46282478-2C2DE1F9-E89B-4BCD-9EF8-9BD446A897FAQ50001301-01C300D2-9A4E-4430-BD45-F2941B1E89D1Q54195862-D37281A8-E639-4F48-9A3A-89037E186A6DQ56669510-3730D3E4-D6E2-434D-9509-04B42E684225Q58578855-173028C3-46C6-4A6B-A0CC-D6DA4DCD9107
P2860
Tumor markers in clinical practice: General principles and guidelines.
description
2009 nî lūn-bûn
@nan
2009 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Tumor markers in clinical practice: General principles and guidelines.
@ast
Tumor markers in clinical practice: General principles and guidelines.
@en
type
label
Tumor markers in clinical practice: General principles and guidelines.
@ast
Tumor markers in clinical practice: General principles and guidelines.
@en
prefLabel
Tumor markers in clinical practice: General principles and guidelines.
@ast
Tumor markers in clinical practice: General principles and guidelines.
@en
P2860
P356
P1476
Tumor markers in clinical practice: General principles and guidelines.
@en
P2093
P2860
P356
10.4103/0971-5851.56328
P577
2009-01-01T00:00:00Z